Radiation physics and genetic targeting: New directions for radiotherapy: The Douglas Lea lecture 1999

Physics in Medicine and Biology

Volumn 45, Issue 7, 2000, Pages

  Wheldon, T E ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 131; MONOCLONAL ANTIBODY;

BEAM THERAPY; CANCER RADIOTHERAPY; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; RADIATION PHYSICS; RADIOBIOLOGY; RADIOSENSITIVITY; REVIEW;

3-IODOBENZYLGUANIDINE; BRAIN NEOPLASMS; GENE THERAPY; GLIOMA; HUMANS; NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY; SODIUM IODIDE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033913390     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/45/7/201     Document Type: Review

References (38)

1. 131I therapy and total body irradiation for treatment of disseminated tumours of differing radiosensitivity Int. J. Radiat. Oncol. Biol. Phys. 27 323-30
2. Boyd M and Wheldon T E 1999 Tumour spheroids Culture of Animal Cells: a Manual of Basic Technique 4th edn, ed R I Freshney (New York: Liss)
3. 131I]meta-iodobenzylguanidine Gene Ther. 6 1147-52
4. Buchsbaum D J, Raben D, Stackhouse M A et al 1996 Approaches to enhance cancer radiotherapy employing gene transfer methods Gene Ther. 3 1042-68
5. Carlsson J and Nederman T 1989 Tumor spheroid technology in cancer therapy research Eur. J. Cancer Clin. Oncol. 25 1127-33
6. de Kraker J, Hoefnagel C A, Caron H et al 1995 First line targeted radiotherapy, a new concept in the treatment of advanced neuroblastoma. Eur. J. Cancer 31A 600-2
7. Epperly M, Bray J, Kraeger S, Zwacka R, Engelhardt J, Travis E and Greenberger J 1998 Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy Gene Ther. 5 196-208
8. Gaze M N and Wheldon T E 1996 Radiolabelled MIBG in the treatment of neuroblastoma Eur. J. Cancer 32A 93-6
9. 131I-meta-iodobenzylguanadine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of an innovative strategy for advanced neuroblastoma Eur. J. Cancer 31A 252-6
10. Gray LH 1947 Orbituary of Douglas Lea Br. J. Radiol. 20 335-6
11. Kaminski M S, Vose J, Saleh M et al 1997 A multicentre phase II study of iodine 131 anti-B1 antibody (Bexxar) in patients with chemotherapy-relapsed/refractory low grade or transformed low grade B-cell non-Hodgkin lymphoma Blood 10 (suppl 1) 2268
12. Kaminski M S, Zasadny K R, Francis I R et al 1996 Iodine-131-anti-B1 radioimmunothcrapy for B cell lymphoma J. Clin. Oncol. 141 1974-81
13. Knuechel R and Sutherland R M 1990 Recent developments in research with human tumor spheroids Cancer J. 3 234-43
14. Kohler G and Milstein C 1975 Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 495-7
15. Lea D H 1955 Actions of Radiation on Living Cells (Cambridge: Cambridge University Press)
16. Liu S Y, Eary J F, Petersdorf S H, Martin P J et al 1998 Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labelled-anti-CD20 antibody and autologous stem cell rescue J. Clin. Oncol. 16 3270-8
17. Lovquist A and Divgi C 1998 Bullets to magic bullets: and miles to go before we sleep [Editorial comment] J. Nucl. Med. 39 1776-7
18. 131I]MIBG) in combination with other agents Eur. J. Cancer 35 1171-3
19. 131I-meta-iodobenzyl guanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction Br. J. Cancer 70 97-101
20. Mandell R B, Mandell L Z and Link C J 1999 Radioisotope concentrator gene therapy using the sodium/ iodide symporter gene Cancer Res. 59 661-8
21. Meller S 1999 Targeted radiotherapy for neuroblastoma Arch. Dis. Child. 77 389-91
22. McKie E A, MacLean A R, Lewis A D, Cruikshank G, Rampling R et al 1996 Selective in vitro replication of herpes simplex type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours - evaluation of a potentially effective clinical therapy Br. J. Cancer 74 745-52
23. Mueller-Klieser W 1987 Multicellular spheroids. A review on cellular aggregates in cancer research J. Cancer Res. Clin. Oncol. 113 101-22
24. O'Donoghue J A 1991 Optimum scheduling of combined biologically targeted radiotherapy and total body irradiation with bone marrow rescue for treatment of systemic malignant disease. Int. J. Radiat. Oncol. Biol. Phys. 21 1587-94
25. O'Donoghue J A, Bardies M and Wheldon T E 1995 Relationships between tumour size and curability for targeted radionuclide therapy J. Nucl. Med. 36 1902-9
26. 131I-meta -iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma Br J. Radiol. 64 428-34
27. Press O W, Eary J F, Appelbaum F R et al 1993 Radiolabelled antibody therapy of B cell lymphoma with autologous bone marrow support New Engl. J. Med. 329 1219-24
28. Raben D, Buchsbaum D J, Khazaeli M B et al 1996 Enhancement of radiolabelled binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene Gene Ther. 3 567-80
29. Rampling R, Cruikshank G, MacLean A and Brown M 1998 Therapeutic replication-competent herpes virus Nat. Med. 4 133
30. Rosenfeld M E, Rogers B E, Khaezeli M B, MikheevaG, Raben D et al 1997 Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo Clin. Cancer Res. 3 1187-94
31. Ross G M, Eady J J, Mithal N P, Bush C, Steel G G, Jeggo P A and McMillan T J 1995 DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human Ku80 gene Cancer Res. 55 1235-8
32. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L et al 1995 A single ataxia telangiectasia gene with a product similar to to P1-3 kinase Science 268 1749-53
33. Stackhouse M A, Buschbaum D J, Kancharia S R, Grizzle W E et al 1999 Specific membrane receptor gene expression targeted with radiolabelled peptides employing the erb-2 and DF3 promoter elements in adenoviral vectors Cancer Gene Ther. 6 209-19
34. Suresh A, Tung F, Moreb J and Zucali J R 1994 Role of manganese superoxide-dismutase in radioprotection using gene-transfer studies Cancer Gene Ther. 1 85-90
35. Tambini C E, George A M, Rommens J M, Tsui L C, Scherer S W and Thacker J 1997 The XRCC2 repair gene : identification of a positional candidate Genomics 41 84-92
36. Walker K A, Mairs R J, Murray T, Hilditch T E, Wheldon T E, Gregor A and Hann I M 1990 Tumour spheroid model for the biologically targeted radiotherapy of neuroblastoma micrometastases Cancer Res. 50 102s-105s
37. Webb S 1997 Conformal Radiotherapy (Bristol: Institute of Physics Publishing)
38. Wheldon T E, Mairs R J, Rampling R P and Barrett A 1998 Modelling the enhancement of radiotherapy by gene transfer to sensitize tumour cells to radiation Radiother. Oncol. 48 5-13